$RGBP Headlines Regen BioPharma Files Patent A
Post# of 72741

Regen BioPharma Files Patent Application on New Therapy That Uses the "Innate" Immune System to Kill Cancer 11:44 a.m. Sept. 16, 2014 - Marketwire
Regen BioPharma Provides Update on HemaXellerate IND Progress After Conference Call With FDA 10:02 a.m. Sept. 10, 2014 - Marketwire

